Polomar Health Services, Inc.
PMHS
$0.12
-$0.02-17.37%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 22,244.44% | 2,924.40% | -36.73% | -62.07% | -66.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22,244.44% | 2,924.40% | -36.73% | -62.07% | -66.91% |
| Cost of Revenue | 32,400.00% | 1,453.39% | 80.00% | -61.90% | -87.16% |
| Gross Profit | 17,103.13% | 4,831.87% | -51.69% | -63.11% | 18.52% |
| SG&A Expenses | 33.16% | 1,245.10% | 136.23% | 182.19% | 156.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 141.05% | 1,248.56% | 136.06% | 177.19% | 141.24% |
| Operating Income | 98.34% | -1,197.74% | -142.59% | -195.39% | -158.82% |
| Income Before Tax | 94.44% | -1,150.54% | -139.51% | -217.57% | -184.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 94.44% | -1,150.54% | -139.51% | -217.57% | -184.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.44% | -1,150.54% | -139.51% | -217.57% | -184.67% |
| EBIT | 98.34% | -1,197.74% | -142.59% | -195.39% | -158.82% |
| EBITDA | 101.66% | 112.30% | -44.41% | -60.87% | 1.08% |
| EPS Basic | 94.55% | -1,147.31% | -136.73% | -217.39% | -184.48% |
| Normalized Basic EPS | 94.17% | -1,151.23% | -137.70% | -218.60% | -186.11% |
| EPS Diluted | 94.55% | -1,096.00% | -136.73% | -217.39% | -184.48% |
| Normalized Diluted EPS | 94.17% | -1,151.23% | -137.70% | -218.60% | -186.11% |
| Average Basic Shares Outstanding | 1.32% | 0.22% | 1.27% | 0.04% | 0.01% |
| Average Diluted Shares Outstanding | 1.32% | 0.22% | 1.27% | 0.04% | 0.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |